Abstract

GCI-PHER-1.0 proposes a modular physical-processing architecture intended to investigate whether differences in viral particle structure, mechanical properties, hydration interfaces and acoustic susceptibility can be exploited to reduce viral infectivity.

The proposed concept combines three research areas:

  1. Hydration-interface and dielectric-field modification.

  2. Differential acoustic and mechanical susceptibility.

  3. Engineered microfluidic transport and particle-retention structures.

The underlying hypothesis is that viral particles may respond differently from surrounding biological materials when exposed to carefully characterized physical conditions.

Rather than relying exclusively on chemical antiviral compounds, the proposed system investigates whether physical mechanisms could contribute to viral structural destabilization, loss of infectivity or subsequent particle separation.

The long-term research ambition is to investigate whether a strain-independent or broadly applicable physical-processing platform might eventually be possible.

This is an aspiration, not a demonstrated result.

The proposed system is initially intended for nonclinical, cell-free research. Any later investigation involving blood components would require separate experimental approval, compatibility assessment and safety validation.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS